{
    "2018-01-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "How Marijuana Acceptance Is Evolving Globally",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Acceptance",
                        "Evolving",
                        "Globally"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Which Biotech Stocks Could Surprise To The Upside On Earnings?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Surprise",
                        "Upside",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Must-Knows before Investing in the Marijuana Industry",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Industry",
                        "Investing",
                        "Must-Knows"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "Amgen/Allergan's Avastin Biosimilar Secures EU Approval",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Allergan",
                        "Avastin",
                        "Biosimilar",
                        "EU",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "Johnson & Johnsonâ€™s Pharmaceutical Segment: 4Q17 Estimates",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Pharmaceutical",
                        "Segment",
                        "4Q17",
                        "Estimates"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-18",
                "original_text": "The Zacks Analyst Blog Highlights: Apple, JPMorgan, AbbVie, Gilead and Simon Property Group",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Apple",
                        "JPMorgan",
                        "AbbVie",
                        "Gilead",
                        "Simon",
                        "Property",
                        "Group"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "pharmaceuticals",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-22",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Johnson",
                        "&",
                        "Johnson",
                        "AbbVie",
                        "Amgen",
                        "Novo-Nordisk",
                        "Zoetis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Amgen/Allergan's Avastin Biosimilar Secures EU Approval",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Allergan",
                        "Avastin",
                        "Biosimilar",
                        "EU",
                        "Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}